Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Marianna Adamo, Volker Rudolph, Marta Sitges ,et al Start date: Dec 03, 2025
Severe tricuspid regurgitation (TR) remains an under-recognised and under-treated condition, stressing the importance of timely identification and referral to improve clinical outcomes.In this interactive session, Prof Marianna Adamo (University of Brescia, Brescia, IT) and Prof Volker Rudolph (Heart and Diabetes Center NRW, Bad Oeynhausen, DE) moderate an expert faculty of Prof Marta Sitges … View more
Author(s): Paul Grayburn Added: 7 months ago
New York Valves 2025 - Echocardiographic outcomes from the TRISCEND II substudy reinforce the effectiveness of TTVR compared to medical therapy alone at one year post transcatheter tricuspid valve replacement (TTVR).Dr Paul Grayburn (Baylor Scott and White Research Institute, Dallas, US) joins us to discuss echocardiographic outcomes one year post TTVR from the TRISCEND II substudy which… View more
Author(s): Ali Vazir , Volker Rudolph , Sam Dawkins , et al Added: 2 months ago
Severe tricuspid regurgitation (TR) remains an under-recognised and under-treated condition, stressing the importance of timely identification and referral to improve clinical outcomes.In this video series, Prof Marianna Adamo (University of Brescia, Brescia, IT) and Prof Volker Rudolph (Heart and Diabetes Center NRW, Bad Oeynhausen, DE) moderate an expert faculty of Prof Marta Sitges (University… View more
Author(s): Julien Dreyfus Added: 8 months ago
EuroPCR 25 - First-in-human outcomes from the TRiCares Topaz Tricuspid Valve Replacement System in patents with tricuspid regurgitation (TR) show positive performance results and improved safety.We are joined by Dr Julien Dreyfus (Centre Cardiologique du Nord, Saint-Denis, FR) to discuss outcomes from the first-in-human, pivotal, multi-centre TRICURE EU study (NCT06581471; TRiCares) investigating… View more
Author(s): Didier Tchétché Added: 1 year ago
TCT Conference 2024 - Safety and efficacy outcomes of transcatheter aortic valve replacement (TAVR) compared to surgical aortic valve replacement (SAVR) in female patients with severe aortic stenosis.Dr Didier Tchétché (Clinique Pasteur, FR) joins us onsite at TCT Conference to discuss the pooled findings from the RHEIA (NCT04160130) and PARTNER 3 (NCT02675114) trials.RHEIA and PARTNER 3 are… View more
Added: 4 months ago Source:  Radcliffe Cardiology
AUTHOR: Jordan RanceInfective endocarditis (IE) is a serious complication following mitral valve (MV) interventions, but long-term data on the comparative risk between different procedures has been limited. A new Danish nationwide study has found that patients undergoing MV replacement have a significantly higher 10-year risk of first-time IE compared to those undergoing MV repair or individuals… View more